Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
PTC Therapeutics, Inc. (PTCT)
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ptcbio.com
Company Research
Source: Yahoo! Finance
Palo Alto Investors LP reported a buy of 41,303 shares of PTC Therapeutics (NASDAQ:PTCT) in its February 17, 2026, SEC filing, with an estimated transaction value of $3.00 million based on quarterly average pricing. What Happened According to a SEC filing dated February 17, 2026, Palo Alto Investors LP increased its position in PTC Therapeutics by 41,303 shares during the fourth quarter of 2025. The estimated transaction value for the additional shares was $3.00 million, based on average closing prices for the quarter. The fund's stake in PTC Therapeutics was valued at $68.66 million at quarter-end, up $15.72 million from the prior period, a change reflecting both increased holdings and price appreciation. What Else to Know Palo Alto Investors LP reported a buy; PTC Therapeutics accounts for 9.56% of 13F reportable AUM as of December 31, 2025. Top holdings after the filing: NASDAQ:INSM: $85.19 million (11.9% of AUM) NASDAQ:FOLD: $74.13 million (10.3% of AUM) NASDAQ:PT
Show less
Read more
Impact Snapshot
Event Time:
PTCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTCT alerts
High impacting PTC Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PTCT
News
- Global Ferroptosis Targeting Therapy Market Opportunity Report 2026: Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights By Company, Country, Indication & Phase [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- PTC Therapeutics to Participate at Upcoming Investor ConferencesPR Newswire
- PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
PTCT
Earnings
- 2/19/26 - Miss
PTCT
Sec Filings
- 3/5/26 - Form 144
- 3/5/26 - Form 144
- 3/5/26 - Form 144
- PTCT's page on the SEC website